NO963572D0 - Inhibin-sammensetninger og fremgangsmåter for bruk av disse - Google Patents
Inhibin-sammensetninger og fremgangsmåter for bruk av disseInfo
- Publication number
- NO963572D0 NO963572D0 NO963572A NO963572A NO963572D0 NO 963572 D0 NO963572 D0 NO 963572D0 NO 963572 A NO963572 A NO 963572A NO 963572 A NO963572 A NO 963572A NO 963572 D0 NO963572 D0 NO 963572D0
- Authority
- NO
- Norway
- Prior art keywords
- protein
- heterologous protein
- inhibin
- heterologous
- fused
- Prior art date
Links
- 239000000893 inhibin Substances 0.000 title abstract 5
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 10
- 108090000623 proteins and genes Proteins 0.000 abstract 10
- 102000014914 Carrier Proteins Human genes 0.000 abstract 4
- 108010078791 Carrier Proteins Proteins 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 241000271566 Aves Species 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 abstract 1
- 241000287530 Psittaciformes Species 0.000 abstract 1
- 229940098773 bovine serum albumin Drugs 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Confectionery (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Dental Preparations (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20296494A | 1994-02-28 | 1994-02-28 | |
| PCT/US1995/002795 WO1995022980A1 (en) | 1994-02-28 | 1995-02-28 | Inhibin compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO963572D0 true NO963572D0 (no) | 1996-08-27 |
| NO963572L NO963572L (no) | 1996-10-25 |
Family
ID=22751927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963572A NO963572L (no) | 1994-02-28 | 1996-08-27 | Inhibin-sammensetninger og fremgangsmåter for bruk av disse |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0804219B1 (no) |
| JP (1) | JPH09510702A (no) |
| CN (1) | CN1149258A (no) |
| AT (1) | ATE220554T1 (no) |
| AU (1) | AU704737B2 (no) |
| BR (1) | BR9507426A (no) |
| CA (1) | CA2184183C (no) |
| DE (1) | DE69527439T2 (no) |
| DK (1) | DK0804219T3 (no) |
| ES (1) | ES2181771T3 (no) |
| FI (1) | FI963325A (no) |
| MX (1) | MX9603702A (no) |
| NO (1) | NO963572L (no) |
| NZ (1) | NZ282981A (no) |
| PL (1) | PL184202B1 (no) |
| PT (1) | PT804219E (no) |
| RU (1) | RU2170100C2 (no) |
| WO (1) | WO1995022980A1 (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786179A (en) * | 1994-02-28 | 1998-07-28 | Agritech Technologies Ltd. | Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same |
| US5725858A (en) * | 1994-02-28 | 1998-03-10 | Agritech Technologies, Ltd. | Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein |
| JP2006523180A (ja) * | 2002-11-07 | 2006-10-12 | アグリテック テクノロジー リミテッド | 鳥類において生産能を促進する新規インヒビン関連複数抗原ペプチド組成物 |
| PL1910395T3 (pl) | 2005-06-23 | 2013-03-29 | Cold Spring Harbor Laboratory | Kompozycja i sposób modulacji splicingu SMN2 |
| EP1930346B1 (en) | 2005-08-29 | 2011-10-19 | Japan Science and Technology Agency | Antibody produced using ostrich and method for production thereof |
| MX361732B (es) | 2009-06-17 | 2018-12-14 | Cold Spring Harbor Laboratory | Composiciones y metodos para la modulacion de division de smn2 en un sujeto. |
| EP2943225A4 (en) | 2013-01-09 | 2016-07-13 | Ionis Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR MODULATING SMN2 DISTRIBUTION IN THE BODY OF A PATIENT |
| BR102014005376A2 (pt) * | 2014-03-07 | 2016-02-10 | Ouro Fino Saúde Animal Ltda | antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica |
| MA39835A (fr) | 2014-04-17 | 2017-02-22 | Biogen Ma Inc | Compositions et procédés de modulation de l'épissage du smn2 chez un patient |
| US10436802B2 (en) | 2014-09-12 | 2019-10-08 | Biogen Ma Inc. | Methods for treating spinal muscular atrophy |
| EP3471779A4 (en) | 2016-06-16 | 2020-07-08 | Ionis Pharmaceuticals, Inc. | COMBINATIONS FOR MODULATING THE SMN EXPRESSION |
| CN110551744A (zh) * | 2019-09-18 | 2019-12-10 | 普健生物（武汉）科技有限公司 | 一种人抑制素a的核苷酸序列及重组表达人抑制素a的方法 |
| PE20221913A1 (es) | 2020-02-28 | 2022-12-23 | Ionis Pharmaceuticals Inc | Compuestos y metodos para modular smn2 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089396A (en) * | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| US4864019A (en) * | 1985-11-08 | 1989-09-05 | The Salk Institute For Biological Studies | Antibodies to inhibin and conjugates produced therefrom |
-
1995
- 1995-02-28 EP EP95913576A patent/EP0804219B1/en not_active Expired - Lifetime
- 1995-02-28 AU AU20959/95A patent/AU704737B2/en not_active Ceased
- 1995-02-28 MX MX9603702A patent/MX9603702A/es not_active IP Right Cessation
- 1995-02-28 JP JP7522532A patent/JPH09510702A/ja not_active Withdrawn
- 1995-02-28 PL PL95316628A patent/PL184202B1/pl not_active IP Right Cessation
- 1995-02-28 ES ES95913576T patent/ES2181771T3/es not_active Expired - Lifetime
- 1995-02-28 DK DK95913576T patent/DK0804219T3/da active
- 1995-02-28 CN CN95192317A patent/CN1149258A/zh active Pending
- 1995-02-28 DE DE69527439T patent/DE69527439T2/de not_active Expired - Fee Related
- 1995-02-28 RU RU96119774/13A patent/RU2170100C2/ru not_active IP Right Cessation
- 1995-02-28 WO PCT/US1995/002795 patent/WO1995022980A1/en active IP Right Grant
- 1995-02-28 NZ NZ282981A patent/NZ282981A/en unknown
- 1995-02-28 PT PT95913576T patent/PT804219E/pt unknown
- 1995-02-28 BR BR9507426A patent/BR9507426A/pt not_active IP Right Cessation
- 1995-02-28 AT AT95913576T patent/ATE220554T1/de not_active IP Right Cessation
- 1995-02-28 CA CA002184183A patent/CA2184183C/en not_active Expired - Fee Related
-
1996
- 1996-08-27 NO NO963572A patent/NO963572L/no unknown
- 1996-08-27 FI FI963325A patent/FI963325A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2095995A (en) | 1995-09-11 |
| DE69527439D1 (de) | 2002-08-22 |
| ES2181771T3 (es) | 2003-03-01 |
| MX9603702A (es) | 1997-12-31 |
| FI963325A (fi) | 1996-10-21 |
| DE69527439T2 (de) | 2003-02-20 |
| EP0804219A1 (en) | 1997-11-05 |
| DK0804219T3 (da) | 2002-11-11 |
| RU2170100C2 (ru) | 2001-07-10 |
| EP0804219B1 (en) | 2002-07-17 |
| CA2184183A1 (en) | 1995-08-31 |
| NO963572L (no) | 1996-10-25 |
| EP0804219A4 (en) | 1999-02-24 |
| ATE220554T1 (de) | 2002-08-15 |
| PL316628A1 (en) | 1997-02-03 |
| WO1995022980A1 (en) | 1995-08-31 |
| NZ282981A (en) | 1998-08-26 |
| PT804219E (pt) | 2002-12-31 |
| JPH09510702A (ja) | 1997-10-28 |
| CN1149258A (zh) | 1997-05-07 |
| PL184202B1 (pl) | 2002-09-30 |
| CA2184183C (en) | 2005-02-08 |
| BR9507426A (pt) | 1997-09-16 |
| AU704737B2 (en) | 1999-05-06 |
| FI963325A0 (fi) | 1996-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Price et al. | Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone | |
| NO963572L (no) | Inhibin-sammensetninger og fremgangsmåter for bruk av disse | |
| Solari et al. | Biosynthesis of the IgA antibody receptor: a model for the transepithelial sorting of a membrane glycoprotein | |
| CA2290485A1 (en) | Method for the production of non-immunogenic proteins | |
| ATE262348T1 (de) | Mittel zur verabreichung von antigenen | |
| IT1203672B (it) | Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina | |
| KR900700116A (ko) | 뼈-유도 단백질 | |
| ATE235250T1 (de) | Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung | |
| DE69637914D1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
| ATE214942T1 (de) | Fibrinogen-bildungsprotein | |
| BR9809656A (pt) | Composição imunopotencializante | |
| Bal et al. | Formation of the extracellular mucous matrix of olfactory neuroepithelium: identification of partially glycosylated and nonglycosylated precursors of olfactomedin | |
| EP0973934A4 (en) | NON-SECRETED PROTEINS PRODUCED TRANSGENICALLY | |
| PL330794A1 (en) | Polypeptides capable of forming structures bonding an antigen exhibiting antigenic specificity in respect to antigenes rh d, dna sequences coding such polypeptides and method of producing and using them | |
| ATE141283T1 (de) | Verfahren zur reinigung eines hochglykosylierten proteins | |
| Cencič et al. | The porcine trophoblastic interferon‐γ, secreted by a polarized epithelium, has specific structural and biochemical properties | |
| AU7526196A (en) | Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands | |
| ATE465751T1 (de) | Verfahren zur vorbeugung und linderung angiogener erkrankungen durch impfung mit dem rezeptor für gbs-toxin (cm101) | |
| Pierre et al. | Mouse secretory component | |
| Pass et al. | Generation of antibodies to the urokinase receptor (uPAR) by DNA immunization of uPAR knockout mice: Membrane‐bound uPAR is not required for an antibody response | |
| Mezzano et al. | ANTIBODY-PRODUCTION AND ANTIGENIC SPECIFIC SUPPRESSION TO BOVINE SERUM-ALBUMIN IN UREMIC RATS | |
| Karkhanis et al. | Antigenic subunit of the polypeptide antigenic complex of the Melvin strain of Neisseria gonorrhoeae | |
| Peng et al. | Cross-reactivity of antibodies to chicken brain choline acetyltransferase with mammalian enzyme | |
| Delaunay et al. | Immunogenic properties of eukaryotic ribosomal proteins | |
| Zikán et al. | Heterogeneity of binding of monoclonal IgA to staphylococcal protein A is related to the IgA polymerization state |